Found 2051 results for "cancer"
A massive structural mismatch in global health funding may be quietly worsening the chronic disease crisis in the world's most vulnerable populations…
For decades, the idea of training the immune system to recognize and destroy a patient's own tumor has tantalized oncologists — yet only one therapeutic…
Stomach cancer remains one of the deadliest malignancies globally, and understanding modifiable risk factors is critical — especially as alcohol consumption…
Hepatocellular carcinoma kills roughly 700,000 people annually worldwide, yet it remains stubbornly resistant to the immunotherapy advances that transformed…
Tuberculosis kills more people annually than almost any other single infectious agent, yet the immune structure that defines the disease — the granuloma — has…
Invasive fungal infections are among medicine's most quietly devastating blind spots — quietly, because they tend to strike people already weakened by cancer…
Every animal cell faces a fundamental vulnerability: without a protective cell wall, the plasma membrane is the last line of defense against lethal rupture…
Cancer treatment has long been hampered by the molecular diversity of oncogenic driver mutations — over a thousand distinct receptor tyrosine kinase (RTK)…
Immune checkpoint inhibitors transformed lung cancer treatment, yet most patients eventually stop responding — a clinical reality that haunts oncologists and…
Photodynamic therapy has long struggled with a fundamental challenge: light does not travel uniformly through living tissue, and what works on average may be…
For the growing number of cancer patients receiving CAR T-cell therapy, neurotoxicity remains one of the most dangerous and treatment-limiting complications…
One of molecular biology's most persistent puzzles concerns the apparent irrationality at the heart of DNA itself. Life on early Earth was bathed in intense…
Detecting liver cancer early enough to intervene meaningfully remains one of oncology's most persistent challenges — missed or delayed diagnoses are common…
When checkpoint inhibitors transformed melanoma treatment, the assumption was that blocking the PD-1 axis alone would be sufficient for most patients. This…
Treating Asian American, Native Hawaiian, and Pacific Islander women as a single cancer-risk category has long masked critical differences across dozens of…
Pancreatic cancer remains one of oncology's most formidable challenges, with five-year survival rates stubbornly below 15%. A core reason is the tumor's…
Chronic low-grade inflammation — sometimes called 'inflammaging' — is one of the most consequential features of biological aging, linked to everything from…
For decades, surgeons have operated on the intuitive premise that removing visible metastatic tumor burden — debulking — should extend survival in stage 4…
Cancer is no longer a disease of wealthy nations or aging populations alone — it is accelerating globally, and the trajectory now quantified by the World…
Why some thyroid cancers behave more indolently than others is a clinically pressing question — and the answer may lie in the immune environment shaped by a…